A Diagnostic Challenge in a Patient with Intractable Nausea and Vomiting: A Case of Systemic Amyloidosis

Ali Ghani; Naveed Ali

Authors

Ali Ghani
Naveed Ali

Keywords:

Abstract

Amyloidosis is a rare disorder caused by deposition of amyloid fibrils in various tissues causing structural and functional defects. Depending upon organs involved, it may be categorized as localized or systemic. Systemic amyloidosis involves multiple organs where some organs are affected more commonly than others. Diagnosis is often challenging as in a 76-yearsold female described here who presented with intractable nausea and vomiting. Clinical course was complicated because of simultaneous presence of peptic ulcer disease and hypothyroidism. Involvement of multiple systems including gastrointestinal tract, thyroid, liver, heart and kidneys was seen, and diagnosis was achieved after renal biopsy showing Congo red staining and apple green birefringence. Gastric and thyroid infiltration by amyloidosis are extremely rare occurrences described very infrequently in the literature. However, to our knowledge, involvement of both organs in a single patient has not been reported in the literature.

Downloads

How to Cite

A Diagnostic Challenge in a Patient with Intractable Nausea and Vomiting: A Case of Systemic Amyloidosis. (2015). Global Journal of Medical Research, 15(39), 1-5. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

References

Rodney Falk, Raymond Comenzo, Martha Skinner (1997) The Systemic Amyloidoses N Engl J Med. 337(13), 898-909. https://doi.org/10.1056/nejm199709253371306

Giampaolo Merlini, Vittorio Bellotti (2003) Molecular Mechanisms of Amyloidosis N Engl J Med. 349(6), 583-596. https://doi.org/10.1056/nejmra023144

Comenzo RL (2009) How I treat amyloidosis. 114(15), 3147-57.

I. How (2012) How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. 120(16), 3206-3213.

Sattianayagam P, Hawkins P, Gillmore J (2009) Amyloid and the GI tract Expert Rev Gastroenterol Hepatol. 3(6), 615-630.

S. Petre, I. Shah, N. Gilani (2008) Review article: gastrointestinal amyloidosis: clinical features, diagnosis and therapy Alimentary Pharmacology and Therapeutics. 27(11), 1006-1016. https://doi.org/10.1111/j.1365-2036.2008.03682.x

Cowan AJ, Skinner M, Seldin DC (2013) Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience Haematologica. 98(1), 141-146. https://doi.org/10.3324/haematol.2012.068155

Said SM, Grogg KL, Smyrk TC (2015) Gastric amyloidosis: clinicopathological correlations in 79 cases from a single institution Hum Pathol. 46(4), 491-498.

Kyle Menke DM, Fleming CR, Oldenburg WA (1993) Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis Mayo Clin Proc. 68(8), 763-767.

R. Leong, K. Nio, L. Plumley, E. Molmenti, Jds Klein (2014) Systemic amyloidosis causing intestinal hemorrhage and pseudo-obstruction. 2014(9).

Koppelman RN, Stollman NH, Baigorri F, Rogers AI (2000) Acute small bowel pseudo-obstruction due to AL amyloidosis: a case report and literature review Am J Gastroenterol. 95(1), 294-296.

Liapis K, Michelis FV, Delimpasi S, Karmiris T (2011) Intestinal pseudo-obstruction associated with amyloidosis Amyloid. 18(2), 76-78.

Katsanos K, Tzambouras N, Christodoulou D, Tsianos EV, Bourantas K (2000) Acute small bowel pseudo-obstruction due to AL-amyloidosis Am J Gastroenterol. 95(11), 3329-3331.

Rich MW (1995) Hypothyroidism in association with systemic amyloidosis Head Neck. 17(4), 343-345.

Mustaqeem Siddiqui, Morie Gertz, Diana Dean (2007) Amyloid goiter as a manifestation of primary systemic amyloidosis Thyroid. 17(1), 77-80. https://doi.org/10.1089/thy.2006.0045

Hamed G, Heffess CS, Shmookler BM, Wenig BM (1995) Amyloid goiter A clinicopathologic study of 14 cases and review of the literature Am J Clin Pathol. 104(3), 306-312.

Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA (2003) Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients Medicine (Baltimore). 82(5), 291-298.

Shin YM (2011) Hepatic amyloidosis The Korean Journal of Hepatology. 17(1), 80.

Son RC, Chang JC, Choi JH (2011) Primary hepatic amyloidosis: report of an unusual case presenting as a mass Korean J Radiol. 12(3), 382.

Wang YD, Zhao CY, Yin HZ (2012) Primary hepatic amyloidosis: a mini literature review and five cases report Ann Hepatol. 11(5), 721-727.

S. Dubrey, K. Cha, J. Anderson (1998) The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. 91(2), 141. https://doi.org/10.1093/qjmed/91.2.141

J. Am (1996) Dubrey SW, Cha K, Simms RW, et al. Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. 77(4), 313-315. https://doi.org/10.1016/s0002-9149(97)89403-9

Comenzo Gertz MA, Falk RH, Tours Amyloidosis, France (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. 79(4), 319-328. https://doi.org/10.1002/ajh.20381

Khalighi MA, Wallace WD, Palma-Diaz MF (2014) Amyloid nephropathy Clinical Kidney Journal. 7(2), 97-106.

von H, Mihatsch M, Lobeck H, Rudolph B, Eriksson M, Röcken C (2009) Prevalence and origin of amyloid in kidney biopsies Am J Surg Pathol. 33(8), 1198-1205.

Desport E, Bridoux F, Sirac C (2012) AL Amyloidosis. 7, 54.